There are several treatments currently available for diabetes, including sodium-glucose cotransporter-2 (SGLT2) inhibitors, dipeptidyl peptidase-4 (DPP-4) inhibitors, biguanides, thiazolidinediones (TZDs), and glucagon-like peptide-1 receptor agonists (GLP-1RAs). Here, SLC5A2 is linked to diabetes mellitus.